STERIS Balance Sheet Health

Financial Health criteria checks 5/6

STERIS has a total shareholder equity of $6.6B and total debt of $2.2B, which brings its debt-to-equity ratio to 33.8%. Its total assets and total liabilities are $10.2B and $3.6B respectively. STERIS's EBIT is $937.8M making its interest coverage ratio 8.1. It has cash and short-term investments of $172.2M.

Key information

33.8%

Debt to equity ratio

US$2.24b

Debt

Interest coverage ratio8.1x
CashUS$172.20m
EquityUS$6.61b
Total liabilitiesUS$3.63b
Total assetsUS$10.24b

Recent financial health updates

Recent updates

STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Dec 14
STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Nov 18

What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Oct 19
What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Is STERIS (NYSE:STE) A Risky Investment?

Oct 01
Is STERIS (NYSE:STE) A Risky Investment?

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Sep 16

Earnings Tell The Story For STERIS plc (NYSE:STE)

Sep 13
Earnings Tell The Story For STERIS plc (NYSE:STE)

Steris: Q2 Numbers Solidify Buy Thesis

Aug 13

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

Aug 08
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

When Should You Buy STERIS plc (NYSE:STE)?

Jul 04
When Should You Buy STERIS plc (NYSE:STE)?

Is STERIS (NYSE:STE) Using Too Much Debt?

Jun 13
Is STERIS (NYSE:STE) Using Too Much Debt?

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15
STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

Steris declares $0.47 dividend

Nov 02

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

Financial Position Analysis

Short Term Liabilities: STE's short term assets ($1.9B) exceed its short term liabilities ($805.5M).

Long Term Liabilities: STE's short term assets ($1.9B) do not cover its long term liabilities ($2.8B).


Debt to Equity History and Analysis

Debt Level: STE's net debt to equity ratio (31.2%) is considered satisfactory.

Reducing Debt: STE's debt to equity ratio has reduced from 36.7% to 33.8% over the past 5 years.

Debt Coverage: STE's debt is well covered by operating cash flow (49.2%).

Interest Coverage: STE's interest payments on its debt are well covered by EBIT (8.1x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 10:04
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

STERIS plc is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Michael PolarkBaird
Erin Wilson WrightBofA Global Research